GPT and Thrombocytopenia: In this study, the combination of oral metronomic topotecan and pazopanib administered daily to pediatric patients with recurrent or refractory solid tumors was well tolerated overall with grade 3 thrombocytopenia and ALT elevation as the only DLTs.